COPD stage2-3
Conditions
Interventions
None listed
Sponsors
National Hospital Organization Takasaki General Medical Center
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1)Diagnosed COPD by spirometry 2)Treated for COPD 3)COPD stage2-3 4)More than 60-year-old 5)Male 6)State that patient can visit a hospital 7)Getting the informed consent by patient or amanuensis
Exclusion criteria
Exclusion criteria: 1)Advanced dementia 2)Performed tracheotomy 3)Acute respiratory failure 4)COPD acute exacerbation within 3 months and received oral or intravenous steroid treatment 5)Having a complication of malignancy terminally 6)Female 7)Treated or scheduled androgen therapy 8)Having an interstitial pneumonia and diagnosed with combined pulmonary fibrosis and emphysema 9)Asthma attack within 3 months and received oral or intravenous steroid treatment 10)Treated with home oxygen therapy 11)Reseachers considered not to be suitable for stury
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| secular change of FEV1 with LOH syndrome | — |
Secondary
| Measure | Time frame |
|---|---|
| secular change 1.respiratory function(VC, %VC, FVC, FEV1, FEV1%, RV, DLCO) 2.skeletal muscle mass 3.nutritional status(height, weight, BMI, TP, Alb) 4.body composition(body cell mass, body fat, body fat percentage, lean body mass, extracellular intracelullar (TBW), moisture content (ECW)) 5.calorific value(basal metabolic rate) 6.inflammation(high-sensitivity CRP) 7.quality of life 8.the correlation between skeletal, muscle mass, nutritional status, body composition, calorific value and quality of life, and FEV1 9.morbidity of LOH syndrome 10.background factor of LOH syndrome 11.effect of LOH syndrome on change of FEV1, skeletal, muscle mass, nutritional status, body composition, calorific value and quality of life | — |
Countries
Japan
Contacts
Public ContactManabu Ueno
National Hospital Organization Takasaki General Medical Center Respiratory Medicine
Outcome results
None listed